{"transactions":[{"id":2410133,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Ophthalmology & CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-07T19:29:53.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":190000,"derivative":{"exercise_price":5.27,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001104659-22-012919","document":"tm225652-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465922012919/tm225652-2_4seq1.xml","form_type":"4"}},{"id":2410132,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Ophthalmology & CMO"}}],"security":"Common Stock","published_at":"2022-02-07T19:29:53.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":63333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 3, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 63,333 shares of common stock of the Company underlying unvested RSUs and (ii) 2 shares of the Company's common stock acquired under the 2014 Ocular Therapuetix, Inc. Employee Stock Purchase Plan on December 31, 2021."}],"balance_after":313335,"source":{"system":"sec-edgar","filing":"0001104659-22-012919","document":"tm225652-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465922012919/tm225652-2_4seq1.xml","form_type":"4"}},{"id":2846333,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Ophthalmology & CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T16:31:58.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":18.31,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-025787","document":"tm217246d5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465921025787/tm217246d5_4seq1.xml","form_type":"4"}},{"id":3294962,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-03T18:27:38.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":215000,"derivative":{"exercise_price":4.39,"expiration_date":"2020-01-29","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0001104659-20-009939","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465920009939/a4.xml","form_type":"4"}},{"id":3507610,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-30T16:10:24.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":12000,"price":2.51,"value":30120.0,"ownership":{"direct":true},"balance_after":25686,"source":{"system":"sec-edgar","filing":"0001104659-19-032741","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465919032741/a4.xml","form_type":"4"}},{"id":3590692,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T18:20:44.000Z","date":"2019-03-15","kind":"purchase","acquired":true,"shares":10000,"price":4.15,"value":41500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,986 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018."}],"balance_after":13686,"source":{"system":"sec-edgar","filing":"0001104659-19-015691","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465919015691/a4.xml","form_type":"4"}},{"id":3704245,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T18:26:25.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":4.1,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-19-000887","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465919000887/a4.xml","form_type":"4"}},{"id":4079367,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-02T16:36:21.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":83500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":83500,"derivative":{"exercise_price":5.47,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":83500},"source":{"system":"sec-edgar","filing":"0001104659-18-006263","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465918006263/a4.xml","form_type":"4"}},{"id":4194904,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-03T17:24:36.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of Goldstein's first date of employment and 2.0833% of the shares vesting monthly thereafter."}],"balance_after":135000,"derivative":{"exercise_price":6.3,"expiration_date":"2027-10-01","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-17-060662","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000110465917060662/a4.xml","form_type":"4"}},{"id":4255393,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option  (right to buy)","published_at":"2017-07-18T20:39:53.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":4.9,"expiration_date":"2027-07-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-018471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000089924317018471/doc4.xml","form_type":"4"}},{"id":4535416,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":130754,"kind":"person","name":"Goldstein Michael H.","position":1,"cik":"0001691259","reported_name":"Goldstein Michael H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option  (right to buy)","published_at":"2016-12-02T18:38:22.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date."}],"balance_after":180000,"derivative":{"exercise_price":8.7,"expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000899243-16-034871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691259/000089924316034871/doc4.xml","form_type":"4"}}]}